Zymeworks (ZYME) shares rose 8% in recent Thursday trading after Leerink Partners upgraded the company's stock to outperform, with a $25 price target.
Trading volume stood at over 600,000 shares against a daily average of 640,000 shares.
Price: 16.86, Change: +1.25, Percent Change: +8.01